Lidocaine patches are a form of local anesthetic that people may use to treat areas of pain on their body. The medication in the patches has a numbing effect on the nerves that send pain signals to ...

Private insurers offer Medicare Advantage (Part C) plans, which may include supplemental benefits for over-the-counter (OTC) drugs or pharmacy items. You may be able to use your plan’s ...

SAN JOSE, Calif., May 30, 2024 /PRNewswire/ -- Teikoku Pharma USA (TPU) announced today that the NMPA (National Medical Products Administration) has approved Lidoderm® ("lidocaine 5% patch as ...

Growing number of generic approved product in the market are expected to augment the lidocaine patches market growth. Patent expiry of Endo Pharmaceuticals for Lidoderm is expected to offer lucrative ...

Amneal has received Food and Drug Administration approval for its lidocaine patch 5%. The product is a generic of Lidoderm Patch 5%. “We are pleased to announce the approval for the Lidocaine Patch, 5 ...

Two pharmaceutical companies will pay the state of California a total of nearly $70 million to settle allegations that they violated antitrust laws by making agreements to delay generic drugs from ...

Pharmaceutical companies are set to pay nearly $70 million to California over “collusive” deals that kept generic drugs off the market and raised prices, state Attorney General Xavier Becerra ...

SAN FRANCISCO (CN) - A federal judge on Thursday finalized two class action settlements worth $270 million, ending four years of litigation over an alleged antitrust conspiracy to keep a generic form ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Teikoku Pharma USA Inc. (“TPU”) today announced that it has entered into an exclusive license agreement with Link Health Group LTD (“Link Health”) to develop market, ...

Pharma has its latest pay-for-delay settlement. In a pair of deals with two plaintiff classes over generic Lidoderm delays, Endo, Teva and Japanese drugmaker Teikoku Seiyaku have agreed to fork over ...